Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia.

Saved in:
Bibliographic Details
Title: Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia.
Authors: Ferguson DC; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences., McCorkle JR; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences., Barnett KR; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences., Bonten EJ; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences., Bergeron BP; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences.; Graduate School of Biomedical Sciences., Bhattarai KR; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences., Yang W; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences., Smith C; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences., Hansen BS; Department of Cell and Molecular Biology and Center for Advanced Genome Engineering, and., Bajpai R; Department of Cell and Molecular Biology and Center for Advanced Genome Engineering, and., Dong Q; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences., Autry RJ; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences., Gocho Y; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences., Diedrich JD; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences., Crews KR; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences., Pruett-Miller SM; Department of Cell and Molecular Biology and Center for Advanced Genome Engineering, and., Roberts KG; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN., Stock W; Hematopoiesis and Hematological Malignancies Program, University of Chicago, Chicago, IL; and., Mullighan CG; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Inaba H; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Jeha S; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Pui CH; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Yang JJ; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Relling MV; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences., Evans WE; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences., Savic D; Hematological Malignancies Program and Center for Precision Medicine in Leukemia.; Department of Pharmaceutical Sciences.
Source: Blood advances [Blood Adv] 2022 Jun 14; Vol. 6 (11), pp. 3386-3397.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2022006965